Form 4 for GEHC GE HealthCare
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001628280-23-002255 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-03 | 2023-02-01 | GEHC | Westrick Thomas J. | CEO, Patient Care Solutions | A - Grant | $0.00 | +1,964 | 14.5K | +16% | $0 |
| D | 2023-02-03 | 2023-02-01 | GEHC | Westrick Thomas J. | CEO, Patient Care Solutions | A - Grant | — | +17.2K | 17.2K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2023-02-01 | A | A | 1,964 | $0.00 | 14,509 | D | — | — | (F1) Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026. (F2) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F3) The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 1,964 newly awarded restricted stock units and 12,545 previously reported restricted stock units. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-02-01 | A | A | 17,244 | — | 17,244 | D | $70.01 · — to 2033-02-01 | 17,244 Common Stock, par value $0.01 per share | (F4) Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. |